Company Overview

Affinity Biopharmaceutical Co., Ltd. is a global, clinical stage biopharmaceutical company focused on advancing innovative technology and first-in-class anti-tumor treatment. We have established our Tumor MicroEnvironment Activated (TMEA) platform technology including TMEA-SMDC, TMEAbody®, TMEAkine®, TMEA-ICE®, ADC and TMEA-XDC platforms, which allow selective unleash of the active drug in the tumor microenvironment.

Integrate Biology and Chemistry, Develop Precision Guided Small Molecule Drugs and Biologics, and Open a New Era of Combination Therapy


Affinity Biopharma is committed to becoming a fully integrated innovative biopharmaceutical company, and building extensive partnerships is at the core of our strategy.

Shanghai Affinity Biopharmaceutical Co.,Ltd.


R&D and Business Development Cooperation:

Address: Suite O, 4th Floor,780 Cailun Road, Pudong, Shanghai, P.R. China